Multiple Chronic Conditions in VLBW Infants: Epidemiology, NICU Care, and Outcome
极低出生体重婴儿的多种慢性疾病:流行病学、新生儿重症监护室 (NICU) 护理和结果
基本信息
- 批准号:8015895
- 负责人:
- 金额:$ 36.71万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Prematurity and its complications are the leading causes of death among children in the first year of life and causes of morbidity lasting for the entire lifespan. Premature and very low birth weight infants (PVLBW, defined as gestational age d 32 weeks and birth weight d 1500g) are 100 times more likely than a normal infant to die in the first year of life, and they are at high risk for developmental delays, functional disabilities, and often have multiple complex chronic conditions affecting the lungs, gut, brain, eyes, and other organs. Specifically, PVLBW children are at high risk for bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), and intraventricular hemorrhages (IVH). We propose to conduct an epidemiologic description of the co-occurrence of these conditions, through a secondary analysis of 15470 premature children admitted to NICUs from 2006- 2010 at 33 children's hospitals in the Pediatric Health Information System (PHIS) database, looking at the effects of these chronic conditions on PVLBW infants receiving care in NICUs. The outcomes of interest include death during the NICU stay, cumulative burden of therapies received during the NICU stay, and re- hospitalization within 30 days following discharge from the NICU. We will: 1) Describe the incidence of the chronic conditions among PVLBW infants during the initial NICU admission, singly and in combination. 2) Describe the associations between the chronic conditions, singly and in combination, and three outcomes of the first NICU admission: death during the NICU stay, the cumulative burden of therapies received during the NICU stay, and re-hospitalization following discharge from the NICU. 3) We will document the consequences of one key intervention on the outcomes: the use of inhaled Nitric Oxide to prevent and treat BPD. The rates of both prematurity and VLBW are rising in the U.S. VLBW occurs at > 2.5 times the rate among blacks compared to the rest of the U.S. population and is therefore a significant vector of health disparities. In all analyses, we will look for evidence of disparate incidence, outcomes, treatment or efficacy of treatment of the chronic conditions based on race or payer status. We will also look for hospital- or region-specific variation in the incidence, outcomes, or treatment of the chronic conditions. Because PVLBW babies are often subject to multiple chronic disorders and are over-represented in an underserved community, they are a priority population for comparative effectiveness research. The proposed study will be significant because it will be the first to systematically describe, in a large sample, the incidence, outcomes, and treatment of multiple co- occurring severe chronic conditions in PVLBW infants, a population experiencing significant mortality and morbidity.
PUBLIC HEALTH RELEVANCE: PROJECT NARRATIVE Premature and very low birth weight (VLBW) infants are at high risk for death, developmental delays, functional disabilities, and often have multiple complex chronic conditions, including bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), and intraventricular hemorrhages (IVH). We propose to conduct an epidemiologic description of the co-occurrence of these conditions, through a secondary analysis of 15470 premature children admitted to NICUs from 2006-2010. The outcomes of interest include death, cumulative burden of therapies received, and re-hospitalization within 30 days following NICU discharge. Prematurity and VLBW are rising in the U.S. VLBW occurs at > 2.5 times the rate among blacks and is therefore a significant vector of health disparities. Because PVLBW babies are often subject to multiple chronic disorders and are over-represented in an underserved community, they are a priority population for comparative effectiveness research.
描述(由申请人提供):早产及其并发症是儿童在出生后第一年死亡的主要原因,也是导致整个生命周期发病的主要原因。早产儿和极低出生体重儿(PVLBW,定义为胎龄32周,出生体重1500克)在出生后一年内死亡的可能性是正常婴儿的100倍,而且他们发育迟缓、功能残疾的风险很高,通常患有影响肺、肠道、大脑、眼睛和其他器官的多种复杂慢性疾病。具体来说,PVLBW儿童发生支气管肺发育不良(BPD)、坏死性小肠结肠炎(NEC)和脑室内出血(IVH)的风险很高。我们建议通过对儿童健康信息系统(PHIS)数据库中33家儿童医院2006- 2010年入住新生儿重症监护病房的15470名早产儿进行二次分析,对这些情况的共同发生进行流行病学描述,观察这些慢性疾病对在新生儿重症监护病房接受护理的PVLBW婴儿的影响。关注的结果包括新生儿重症监护病房住院期间的死亡、新生儿重症监护病房住院期间接受治疗的累积负担以及出院后30天内的再次住院。我们将:1)描述PVLBW婴儿在NICU首次入院时的慢性疾病发生率,单独和联合。2)描述慢性疾病(单独或联合)与首次入住NICU的三个结局之间的关系:NICU住院期间死亡,NICU住院期间接受治疗的累积负担,以及出院后再次住院。3)我们将记录一项关键干预措施对结果的影响:使用吸入一氧化氮预防和治疗BPD。在美国,早产和超长体重的比率都在上升。超长体重在黑人中的发生率是美国其他人口的2.5倍,因此是健康差异的一个重要载体。在所有的分析中,我们将寻找基于种族或付款人身份的不同发病率、结果、治疗或治疗效果的证据。我们还将寻找医院或地区在发病率、结果或慢性疾病治疗方面的差异。由于PVLBW婴儿通常患有多种慢性疾病,并且在服务不足的社区中比例过高,因此他们是比较有效性研究的优先人群。这项拟议的研究将具有重要意义,因为它将是第一个在大样本中系统描述PVLBW婴儿多重并发严重慢性疾病的发病率、结局和治疗的研究,PVLBW婴儿的死亡率和发病率都很高。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM GARDNER其他文献
WILLIAM GARDNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM GARDNER', 18)}}的其他基金
Pharmaceutical Safety Tracking (PhaST): Managing Medications for Patient Safety
药品安全跟踪 (PhaST):管理药物以确保患者安全
- 批准号:
7362688 - 财政年份:2007
- 资助金额:
$ 36.71万 - 项目类别:
Pharmaceutical Safety Tracking (PhaST): Managing Medications for Patient Safety
药品安全跟踪 (PhaST):管理药物以确保患者安全
- 批准号:
7492248 - 财政年份:2007
- 资助金额:
$ 36.71万 - 项目类别:
Pharmaceutical Safety Tracking (PhaST): Managing Medications for Patient Safety
药品安全跟踪 (PhaST):管理药物以确保患者安全
- 批准号:
7670281 - 财政年份:2007
- 资助金额:
$ 36.71万 - 项目类别:
Authorship and Conflicts of Interest in Clinical Trails
临床试验中的作者身份和利益冲突
- 批准号:
7058768 - 财政年份:2004
- 资助金额:
$ 36.71万 - 项目类别:
Authorship and Conflicts of Interest in Clinical Trails
临床试验中的作者身份和利益冲突
- 批准号:
6829333 - 财政年份:2004
- 资助金额:
$ 36.71万 - 项目类别:
Authorship and Conflicts of Interest in Clinical Trails
临床试验中的作者身份和利益冲突
- 批准号:
6945793 - 财政年份:2004
- 资助金额:
$ 36.71万 - 项目类别:
Research Integrity in Pharmacologic Clinical Trials
药理学临床试验中的研究完整性
- 批准号:
6895322 - 财政年份:2001
- 资助金额:
$ 36.71万 - 项目类别:
Research Integrity in Pharmacologic Clinical Trials
药理学临床试验中的研究完整性
- 批准号:
6529789 - 财政年份:2001
- 资助金额:
$ 36.71万 - 项目类别:
Research Integrity in Pharmacologic Clinical Trials
药理学临床试验中的研究完整性
- 批准号:
6407010 - 财政年份:2001
- 资助金额:
$ 36.71万 - 项目类别:
相似海外基金
Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults with Multiple Chronic Conditions: A Sequential, Multiple Assignment, Randomized Trial
优化对患有多种慢性病的老年人进行远程医疗的减肥干预:一项序贯、多项分配、随机试验
- 批准号:
10583917 - 财政年份:2023
- 资助金额:
$ 36.71万 - 项目类别:
Sleep and circadian rhythm disturbances as risk and progression factors for multiple chronic pain conditions
睡眠和昼夜节律紊乱是多种慢性疼痛的风险和进展因素
- 批准号:
10733999 - 财政年份:2023
- 资助金额:
$ 36.71万 - 项目类别:
The Impact of Nurse Practitioner Work Environment and Community Characteristics on Acute Care Utilization by Older Adults with Multiple Chronic Conditions
执业护士工作环境和社区特征对患有多种慢性病的老年人使用急性护理的影响
- 批准号:
10672028 - 财政年份:2023
- 资助金额:
$ 36.71万 - 项目类别:
An end-to-end informatics framework to study Multiple Chronic Conditions (MCC)'s impact on Alzheimer's disease using harmonized electronic health records
使用统一的电子健康记录研究多种慢性病 (MCC) 对阿尔茨海默病的影响的端到端信息学框架
- 批准号:
10728800 - 财政年份:2023
- 资助金额:
$ 36.71万 - 项目类别:
Multiple Chronic COnditions: MultiPle dAta SouRcEs (MC COMPARE)
多种慢性病:多种数据源(MC COMPARE)
- 批准号:
10726452 - 财政年份:2023
- 资助金额:
$ 36.71万 - 项目类别:
DEVELOPMENT OF AN ELECTRONIC CARE PLAN FOR PERSONS WITH MULTIPLE CHRONIC CONDITIONS (E-CARE)
为多种慢性病患者制定电子护理计划 (E-CARE)
- 批准号:
10718544 - 财政年份:2022
- 资助金额:
$ 36.71万 - 项目类别:
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
COVID-19 关闭:医疗保健中断对纽约市多种慢性病患者心血管健康差异的影响。
- 批准号:
10707047 - 财政年份:2022
- 资助金额:
$ 36.71万 - 项目类别:
Examining Psychosocial Factors of Chronic Disease Control to Improve Outcomes for Patients with Multiple Chronic Conditions
检查慢性病控制的心理社会因素以改善多种慢性病患者的治疗结果
- 批准号:
10535530 - 财政年份:2022
- 资助金额:
$ 36.71万 - 项目类别:
COVID-19 shutdown: impact of healthcare disruptions on cardiovascular health disparities among people with multiple chronic conditions in New York City.
COVID-19 关闭:医疗保健中断对纽约市多种慢性病患者心血管健康差异的影响。
- 批准号:
10436056 - 财政年份:2022
- 资助金额:
$ 36.71万 - 项目类别:
A Novel Method for Measuring Goal-Concordant Care in Seriously Ill Older Adults with Multiple Chronic Conditions
一种测量患有多种慢性病的重病老年人的目标一致护理的新方法
- 批准号:
10350948 - 财政年份:2022
- 资助金额:
$ 36.71万 - 项目类别: